中枢神经系统瘤与BCL6核心压力器内部并列重复:长期幸存者的治疗过程
Mohamad Bakkar1, Deniz Altinok2, William J Kupsky3
1Pediatrics, Children's Hospital of Michigan, Detroit, MI.
Journal of pediatric hematology/oncology
|June 14, 2023
概括
一个新发现的中枢神经系统 (CNS) 瘤与BCOR内部合重复 (ITD) 在一个儿科患者中成功地用焦点辐射治疗. 这一案例突出了这种罕见的中枢神经系统恶性瘤的独特管理方法.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 儿科瘤学 儿科瘤学
背景情况:
- 中枢神经系统 (CNS) 瘤与BCL6核心压缩器 (BCOR) 内部合重复 (ITD) 是神经病理学中最近定义的一个实体.
- 由于它们的罕见性,BCOR ITD阳性中枢神经系统瘤的临床和管理环境在很大程度上仍未确定.
研究的目的:
- 报告诊断为中枢神经系统瘤与BCOR ITD的儿科患者的临床过程和治疗.
- 为了突出这种罕见的中枢神经系统恶性瘤的独特治疗方法.
- 为了对BCOR ITD中枢神经系统瘤现有的有限文献做出贡献.
主要方法:
- 一个6岁男孩的病例报告,有一个超门质量.
- 诊断工作包括计算机断层扫描,磁共振成像和分子分析.
- 治疗包括焦点辐射疗法 (54 Gy).
主要成果:
- 最初的病理学表明是亚塑性脑膜瘤,但分子分析证实中枢神经系统瘤与BCOR外子15 ITD.
- 患者接受了焦点辐射疗法.
- 在治疗结束48个月后,没有发现疾病复发的证据.
结论:
- 带有BCOR ITD的中枢神经系统瘤是2021年世卫组织中枢神经系统瘤分类中的一个独特的诊断实体.
- 焦点辐射疗法在儿童病例中证明了治疗这种罕见的中枢神经系统瘤的有效性.
- 进一步的研究和病例报告对于制定BCOR ITD中枢神经系统瘤的治疗指南至关重要.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
